Sivelestat
Drug profile
Also known as: elaspol, sivelestat sodium, sivelestat sodium hydrate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Sivelestat is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including Elane, ELANE and PRTN3. Recorded indications include Acute lung injury.
- Molecular targets: Elane, ELANE, PRTN3 and FAP (4 listed in DrugCentral).
- Indications: Acute lung injury.
- Molecular formula: C20H22N2O7S; molecular weight 434.47 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Acute lung injury
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Neutrophil elastase | Elane | unknown | IC50 6.84 |
| Neutrophil elastase | ELANE | unknown | Ki 6.70 |
| Myeloblastin | PRTN3 | unknown | IC50 6.47 |
| Prolyl endopeptidase FAP | FAP | unknown | Ki 6.23 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | PMDA | — | — |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Interstitial lung disease | 61.7 |
| Therapy non-responder | 53.4 |
Chemical structure
| Molecular formula | C20H22N2O7S |
|---|---|
| Molecular weight | 434.47 g/mol |
| CAS number | — |
| InChIKey | BTGNGJJLZOIYID-UHFFFAOYSA-N |
| PubChem CID | 107706 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Sivelestat used for?
DrugCentral lists the following indications for Sivelestat: Acute lung injury.
How does Sivelestat work?
Its molecular targets in DrugCentral include Elane, ELANE, PRTN3 and FAP.
What is the chemical formula of Sivelestat?
Sivelestat has the molecular formula C20H22N2O7S and a molecular weight of 434.47 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2452 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3182314 — compound record and bioactivity
- PubChem CID 107706 — chemical identifiers
- DrugBank DB12863 — drug record
- FDA UNII DWI62G0P59 — substance identity
- UniProt P08246 (ELANE) — target protein
- UniProt P24158 (PRTN3) — target protein
- UniProt Q12884 (FAP) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.